Overview

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and the safety of the treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Sanofi
Treatments:
Cisplatin
Docetaxel